Closed-loop Medtronic 780G System in Youth With Type 1 Diabetes

Recruiting now

Conditions studied: Type 1 Diabetes, Child, Only

In brief

The goal of this observational study is to describe data on Israeli children and youth using the 780G system including data regarding glycemic control parameters, various questionnaires, sleep data, bioimpedance measures, and dietary parameters. The main questions it aims to answer are: • whether the 780G system will improve glycemic control • whether the psychosocial aspects will improve. Participants will be followed once connected to 780G, at baseline, one, three, six months, 1 year, and two years after the connection.

Key facts

Study ID

NCT05908708

Run by

Sheba Medical Center

People needed

120

Starts

2023-06-01

Expected to finish

2026-07-01

Last updated by the study team

2026-04-09

Who can join

Age: 1 and older, up to 21. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of type 1 diabetes Diabetes duration ≥ 6 months Routine attendance at clinic visits Initiation of 780G system usage

You may not qualify if…

• Children under the age of 1 year Children without 780G system

Where it is running

• Sheba Medical Center — Ramat Gan, Please Select, Israel (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.